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Purpose: Corneal endothelial cells (EC) are crucial for maintaining corneal clarity before and after keratoplasty. Since it
is thought that corneal graft rejection leads to irreversible EC loss and transplant failure, we quantified immune mediated
EC loss in the rat keratoplasty model and analyzed whether the EC layer would then regenerate.
Methods:  Rats  were  subjected  to  orthotopic  penetrating  keratoplasty.  We  compared  endothelial  responses  to
immunological EC loss following allogeneic transplantations between Fisher and Lewis rats (group R) to those following
mechanical EC removal in a syngeneic setting between Lewis rats (group S). Animals were followed clinically for corneal
opacity for up to one year. Bulbi were excised and prepared for histological examination at different time points: ECs
were defined and characterized using Alicarin red S/ DAPI staining on corneal flatmounts. Ki-67/ DAPI staining on
flatmount preparations served to detect cell proliferation. Immunohistochemical staining of corneal cryosections was used
to characterize infiltrating immune cells.
Results: Group R: After about two weeks the allografts were completely opaque, which was accompanied by a massive
leukocyte infiltration in conjunction with EC destruction, signifying rejection. EC loss without an immune reaction (group
S) resulted only in medium opacity levels. In both groups, all grafts regained clarity in the following weeks to months,
and a newly-formed endothelial cell layer with irregular and enlarged ECs became apparent on the formerly EC free grafts.
Scattered Ki-67 positive cells within the endothelial cell layer were observed during re-endothelialization. In addition to
re-endothelialization, the immunological infiltration seen in the allografts at the time of rejection had subsided after one
year.
Conclusions: Re-endothelialization following keratoplasty takes place in the rat in vivo and restores graft clarity,
following both immunological or surgical destruction of ECs. Following rejection, EC replacement is accompanied by a
reduction of immune infiltrates. Peripheral recipient ECs are a sufficient source for graft re-endothelialization, as seen in
rats following EC removal. Our results suggest that ECs both proliferate and enlarge during re-endothelialization in the
rat keratoplasty model.
A clear cornea is essential for good visual acuity. This
requires  an  intact  corneal  endothelium,  which  actively
dehydrates the corneal stroma and thereby prevents corneal
edema and concomitant opacification. Since this cell layer
does not regenerate in vivo in humans, a constant and age-
dependent loss of corneal endothelial cells occurs. Any form
of  corneal  damage  by  inflammatory  processes  or  by
mechanical  trauma  following  intraocular  surgery  or
penetrating injury can lead to additional endothelial cell loss.
Once the endothelial cell (EC) density falls below a critical
number,  corneal  decompensation  follows.  In  such  cases,
transplantation of a full-thickness corneal graft or isolated
endothelial cell layer is the only therapy to restore corneal
clarity  in  the  long  run.  It  is  also  imperative  thereafter  to
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maintain a high endothelial cell count on corneal grafts to
guarantee corneal clarity.
Physiologic  EC  loss  is  accelerated  further  following
penetrating  keratoplasty  (PKP)  [1-4].  Surgical  trauma  or
immunological factors leading to accelerated loss of corneal
endothelial  cells  are  discussed  in  this  context.  Following
lamellar endothelial keratoplasty (DSAEK), an increasingly
popular  technique  [5],  EC  loss  seems  to  be  even  more
pronounced  than  following  PKP  [6,7].  Therefore,  better
understanding  of  the  mechanisms  of  EC  regeneration
following  keratoplasty  is  an  important,  topical  matter  of
concern.
Today, evidence suggests that at least some endothelial
cells are capable of dividing and proliferating in humans as
well [8-12]. According to in-vitro assays, these cells appear
to reside in the corneal periphery primarily [13]. Still, the
knowledge regarding mechanisms and dimensions of corneal
EC regeneration in vitro and in vivo is limited. Endothelial
regeneration in vivo has mainly been studied in corneal injury
models such as corneal freezing or scraping. There have been
Molecular Vision 2010; 16:2368-2375 <http://www.molvis.org/molvis/v16/a254>
Received 13 April 2010 | Accepted 5 November 2010 | Published 11 November 2010
© 2010 Molecular Vision
2368reports that corneal ECs in the rabbit, cat or rat can migrate
and  to  some  extent  proliferate  to  cover  defects  [14-17].
However,  surprisingly  little  is  known  about  endothelial
reactions  following  corneal  transplantation.  While  it  is
commonly assumed that rejection leads to permanent EC loss,
some authors reported restoration of corneal clarity following
rejection [18,19], which would require a functionally intact
endothelial cell layer. Despite these interesting observations,
the extent and mechanisms of EC regeneration in vivo are
poorly  understood.  A  better  understanding  of  corneal  EC
regeneration is necessary for investigating new therapeutic
approaches such as raising endothelial cell counts for corneal
transplants  before  surgery,  enhancing  tissue  engineering
techniques  for  the  ex-vivo  cultivation  of  endothelial  cell
sheets,  or  mechanisms  to  decelerate  endothelial  cell  loss
following surgery.
The  rat  keratoplasty  model  is  widely  used  to  study
immunological  responses  following  keratoplasty.  Most
authors analyze mechanisms that lead to rejection, or seek
therapeutic strategies that prevent allograft failure. In these
studies,  analyses  terminate  with  the  onset  of  rejection.
Opacification  is  generally  equalized  with  rejection,  and
complete  endothelial  cell  rejection  or  loss  is  assumed.
However,  few  investigations  have  focused  on  the  actual
endothelial  response  following  penetrating  allogeneic
keratoplasty itself. We therefore investigated the regenerative
capacity of corneal endothelial cells in vivo in rat PKP, and
assessed  EC  regeneration  following  immunological  and
surgical EC loss.
METHODS
Groups:  To  analyze  potential  differences  in  endothelial
reaction to EC loss due to rejection (immunological cause) or
mechanical cell loss (surgical procedure), two experimental
groups  were  analyzed  (“group  R”  and  “group  S”),  and
compared to controls (“control group”):
Group  R  (rejection  group);  Allogeneic  corneal
transplantations were performed using Fisher rats as donors
and Lewis rats as recipients. In this rat PKP model, a minor
mismatch leads to a 100% rejection rate, which is thought to
be accompanied by EC loss. Group S (surgical group); A
corneal  transplant  without  endothelium  (mechanical
endothelial  abrasion  before  transplantation)  was
syngeneically  grafted  using  Lewis  rats  as  donors  and
recipients,  respectively.  Control  group;  Syngeneic
transplantations with intact endothelium served as controls.
Animals: All animals were handled in accordance with the
ARVO Statement for the Use of Animals in Ophthalmic and
Vision Research. Fisher and Lewis rats (>8 weeks old) were
obtained from Charles River, Sulzfeld, Germany.
Corneal  transplantation  and  definition  of  graft  rejection:
Orthotopic  corneal  transplantations  were  performed  as
previously reported [20]. Briefly, animals were anesthetized
by isoflurane inhalation, followed by intraperitoneal injection
of a mixture of Ketaminehydrochloride 100 mg/kg, Atropine
and Xylazine 0.5 mg/kg. Before surgery, mydriatic eye drops
were  applied  topically.  Donor  and  recipient  corneas  were
trephined with a 2.5 or 2.0 mm trephine, respectively. In group
S, the donor corneas’ EC layer was mechanically abraded with
a hockey knife before transplantation. The graft was fixed
with 8 interrupted sutures (11.0 Ethilon; Ethicon, Norderstedt,
Germany).  We  then  administered  a  tarsorrhaphy,  which
remained in place for the first three postoperative days. As
previously described, all grafts were repeatedly analyzed for
corneal  opacity  according  to  an  international  score  [20].
Corneal graft opacity was graded as follows: 0: completely
transparent corneal graft; 1: slight corneal graft opacity, but
details of iris vessel easily visible; 2: moderate corneal graft
opacity,  iris  vessels  still  visible;  3:  strong  corneal  graft
opacity, only pupil margin visible; 4: complete corneal graft
opacity, pupil not visible. Rejection was defined as complete
graft opacity (grade 4). Animals with surgical complications
such as intraocular hemorrhage or cataract were excluded.
Histological examination:
Cryosections—Bulbi  were  enucleated  and  frozen  in
liquid nitrogen at different time points (day 0, day 15, 6 weeks,
or one year following keratoplasty). To detect immunological
infiltration of the cornea, cryosections were stained using the
Streptavidin-AP  (DAKO,  Glostrup,  Denmark)  method.
Primary antibodies against CD4 (clone W3/25), CD8 (clone
OX-8), CD25 (clone Ox 39), CD161 (clone 10/78), CD163
(clone ED2) and for dendritic cells (OX62) were used (all
from AbD Serotec, Kidlington, UK). Negative controls were
performed using isotype antibodies (mouse IgG1; BioLegend,
Uithoorn, Netherlands). Biotinylated rabbit-anti-mouse IgG
was used as secondary antibody (DAKO). To perform cell
counts, pictures of three microscopic fields in the superior
third of transplants in the central region of the graft were taken
and analyzed using a microscopic camera (Carl Zeiss, Jena,
Germany)  and  analysis  software  (Olympus,  Hamburg,
Germany).  All  evaluations  were  performed  by  two
independent investigators blinded to the experimental group.
Flatmounts—To assess the endothelial cells, bulbi were
enucleated and the corneas excised. Flatmounts were prepared
with the endothelial side facing upwards and stained with
Alicarin red S for 1.5 min (pH=4.3) and cell nuclei were
counterstained with DAPI (4′,6-Diamidino-2-phenylindole;
Sigma-Aldrich,  Munich,  Germany).  Cell  density  was
evaluated in the transplant’s central and border areas as well
as the peripheral recipient cornea (Carl Zeiss microscope and
‘analySIS’-software, Olympus).
To  detect  proliferating  cells,  corneal  flatmounts  were
fixed with acetone (30 min at −20 °C), blocked with PBS
containing 2% BSA and 0.3% TritonX (Sigma-Aldrich) and
stained  with  anti-  Ki-67  antibody  (clone  Mib-1;  BD
Biosciences,  Erembodegem,  Belgium)  overnight  at  room
temperature. As secondary antibody, biotinylated rabbit-anti-
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2369mouse IgG (DAKO) was used, followed by incubation with
Streptavidin-FITC  (AbD  Serotec).  DAPI  was  used  to
counterstain  cell  nuclei.  Cells  were  visualized  using  a
fluorescence microscope and appropriate filters (Carl Zeiss).
Statistical analysis: Graft survival was analyzed using the
Kaplan–Meier survival method. The groups’ cell counts were
compared  using  the  t-test.  A  p<0.05  was  regarded  as
statistically significant.
RESULTS
Endothelial cell loss on rejected corneal allografts (group R):
Allogeneic corneal transplantation was performed between
Fisher and Lewis rats (group R). All allografts were rejected
after a median time of 15 days following surgery (Figure 1A;
n=16). Rejected transplants showed EC loss on the graft site,
while the endothelium of the host cornea was fully intact
(Figure 1B,C). In contrast, the EC layer was intact at the
corresponding time point following syngeneic controls, where
no rejection occurred (Figure 1D,E).
Surgical endothelial abrasion and associated endothelial cell
loss (group S): To further analyze the endothelial response to
EC loss following keratoplasty, we introduced a syngeneic
model  with  removal  of  the  graft  endothelium  before
transplantation  (group  S).  These  animals  showed  initially
moderate graft opacification, which subsequently decreased.
None of the grafts reached an opacity of 4, thus according to
our grading system no rejections occurred (Figure 1A; n=11).
Alicarin  red  staining  directly  following  surgical
endothelial removal (day 0) confirmed the total absence of
graft endothelial cells but intact host endothelium (Figure 2A).
Controls that did not undergo endothelial abrasion revealed
endothelial cells on the host cornea as well as on the graft
immediately  following  transplantation  (Figure  2B).  Thus,
surgical endothelial removal before syngeneic surgery is an
adequate  model  to  examine  possible  re-endothelialization
following keratoplasty without immunological influences.
Restoration of corneal clarity: The animals of group S were
followed clinically for 6 weeks, and those of group R for up
to  one  year  after  surgery.  In  both  groups,  all  corneal
transplants regained clarity despite prior complete endothelial
cell loss.
In  group  R,  all  transplants  experienced  rejection  and
complete  graft  opacity  approximately  two  weeks  after
surgery.  About  another  six  weeks  later  (day  60),  the
transplants  which  had  previously  shown  complete  graft
opacity showed a marked reduction of opacity levels to grade
1. Similarly, in group S, six weeks after syngeneic endothelial
cell-free  keratoplasty  (day  42),  the  grafts  demonstrated  a
clinical follow-up similar to group R’s with marked reduction
of opacity as well (Figure 3). We extended the follow-up of
eight of the allogeneic animals to one year. In this time, graft
clarity remained stable or further decreased in all grafts.
Figure 1. Endothelial cell loss on rejected corneal allografts. A: Kaplan–Meier survival analysis: 100% rejection rate of allografts (group R),
no rejections for syngeneic controls with endothelium (control group) or following mechanical endothelial removal before syngeneic
transplantation (group S). B, C: Group R: Endothelium at the time of rejection (day 15 after surgery). B: Staining with Alicarin red S. C: Same
cut, DAPI staining of cell nuclei. Superior; Intact host endothelium; Inferior: Graft with endothelium destroyed following immune reaction.
Arrow: Suture in the underlying stroma, indicating the graft border. D, E: Control group: Endothelium of untreated syngeneic controls at the
corresponding time point. Superior: Intact host endothelium; Inferior: Intact graft endothelium. Arrow: Suture in the underlying stroma,
indicating the graft border.
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2370Endothelial regeneration: Since the restoration of corneal
clarity is only supposed to be possible with a functionally
intact  EC  layer,  we  performed  Alicarin  red  S  stainings
counterstained  with  DAPI  on  corneal  flatmouts  to
demonstrate corneal ECs on the graft.
Group  S:  The  denuded  graft  (Figure  4A)  had  been
repopulated by recipient ECs (Figure 4C) during the weeks
following  endothelial  cell-free  keratoplasty.  These  cells
presented  pronounced  polymorphia  and  cell  enlargement
(Figure  4C,E).  The  area  of  abnormal  endothelial  cells
extended from the graft onto the adjacent recipient cornea. As
shown in Figure 4E, mean EC density was reduced on the
graft, whereas no significant changes were apparent on the
peripheral host cornea.
Group R: Re-endothelialization also occurred in group R,
similarly  to  group  S.  While  the  graft  endothelium  was
destroyed at the time of rejection (Figure 4B), regeneration
with a layer of polymorphic ECs occurred on the graft in the
following weeks (Figure 4D).
To  discover  whether  the  host  endothelial  cells  only
expand and migrate onto the graft or additionally also divide
and  proliferate,  we  performed  Ki-67  stainings  on  corneal
flatmounts. In the area adjacent to the graft and on the graft,
but not in the periphery of the host cornea, Ki-67 stainings
within  the  endothelial  cell  layer  revealed  scattered  EC
divisions  (Figure  4F).  The  partner  eyes  of  these  animals,
which did not undergo surgery, showed an endothelial cell
layer  which  was  completely  negative  for  Ki-67.  The
Figure 2. Corneal graft (border zone) on the day of surgery. A: Group S: Transplantation of endothelium-free transplant after endothelial
debridement. The host endothelium is intact, while the graft is devoid of endothelium (see magnification). B: Control group: Transplantation
of an untreated graft with endothelium visible on the host cornea and the graft (magnification) directly following surgery. Straight arrow:
Suture indicating graft border. Alicarin red S flatmount staining; Magnification: Overview 100×, details 400×.
Figure 3. Corneal opacity following keratoplasty. Group R (left): Allogeneic transplantation. Rejection defined as complete graft opacity
(opacity grade 4) occurred on average on day 15 after keratoplasty (n=16). All grafts regained clarity in the following weeks to months (follow-
up 60 days: n=8, follow-up 1 year: n=8). Group S (middle): syngeneic transplantation of a transplant with surgically removed endothelium.
After initially higher opacity compared to the allogeneic group, opacity never reached the maximum grade of 4, thus no rejection occurred
(n=11). Control group (right): syngeneic transplantation without prior endothelial alteration. Initial opacity levels are lower compared to the
EC-free syngeneic grafts from group S (n=8). (Shown: median±upper/lower quartile).
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2371epithelium  of  the  corneal  flatmounts  served  as  internal
controls, were cell divisions primarily in the periphery could
be detected in all preparations.
Opacity and immunological infiltration: Since syngeneic EC-
free grafts only achieved opacity scores of 2–3 and did not
attain maximum opacity (grade 4) like the allogeneic rejected
grafts, immunological factors – aside from a damaged EC
layer – must be responsible for opacity grades of 4. Therefore,
the  immunological  infiltrate  was  analyzed  in  corneal
allografts at the rejection time point and one year following
PKP (Figure 5).
At the time of rejection, all allografts showed strong
infiltration  of  CD45+  leukocytes.  Further
immunohistochemical  analyses  revealed  a  pronounced
infiltrate with T-cells (CD4+, CD8+), CD25+ cells, CD161+ NK
cells, and CD163+ macrophages, whereas few dendritic cells
(OX62+) were present (Figure 5A). A clinical example of a
rejected and infiltrated graft is illustrated in Figure 5B. One
year following complete rejection, the cellular infiltrate was
significantly reduced, except for dendritic cells (Figure 5C).
This correlated with a clinically clear allograft as shown in
Figure 5D.
DISCUSSION
The rat keratoplasty model is a widely used model for corneal
transplantation [21]. Allogeneic corneal transplantation using
adult rats of Fisher strain as donors and adult Lewis rats as
recipients leads to a 100% rejection rate and is thus is a reliable
model  for  studying  immunological  responses  [22,23].  A
rejected graft shows complete corneal opacification, and in
most studies, the animals are sacrificed at this time point. In
contrast, we have extended the follow-up time up to one year
following  corneal  transplantation,  and  noted  that  all
transplants that had undergone rejection regained clarity.
Allogeneic  corneal  transplantation  with  subsequent
rejection is thought to be associated with permanent EC loss
in both humans [24,25] and rodent models of penetrating
keratoplasty [26,27]. However, we observed that the rejected
grafts cleared up again. This would require a functioning
endothelial cell layer on the graft. In fact, we observed a loss
of endothelial cells due to the immunological response, with
Figure 4. Endothelial regeneration. A,
B: No endothelial cells visible on the
grafts,  while  the  host  endothelium  is
intact.  A:  First  day  after  corneal
transplantation  of  an  endothelial  cell-
free syngeneic graft of group S. B: Time
of rejection in group R. C, D: Six weeks
later newly-formed endothelial cells are
visible on the grafts. These cells show
an irregular shape and are larger than
those  in  the  peripheral  recipient
endothelium (C: Group S; D: Group R).
A-D:  Superior:  Host  cornea;  Inferior:
Graft.  Black  lines:  Sutures  indicating
the  graft  border.  Magnification  100×.
E:  Following  re-endothelialization  in
group S, mean endothelial cell density
on the graft is markedly lower than on
the  host  cornea  (Group  S,  n=11).  F:
Ki-67 (MIB-1) immunostains (green) of
a corneal flatmount counterstained with
DAPI  (blue)  shows  endothelial  cell
division  (arrow)  of  host  endothelium
adjacent to the graft (6 days following
surgery). Magnification 630×.
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2372an almost complete absence of endothelial cells following
rejection,  and  subsequent  re-endothelialization  in  the
following weeks to months.
However,  very  little  is  known  about  recovery  from
opacification or re-endothelialization following keratoplasty
in the rat. Williams and Coster, who introduced a penetrating
rat keratoplasty model in 1985 with Fisher rats as recipients
and DA rats as donors, described that, out of 21 allografts to
prevascularized corneal beds (all of which became “thick and
cloudy” within 12 days postgraft), 5 regained clarity 3 to 4
weeks following keratoplasty. However, since they provided
neither  grades  of  opacity  nor  exact  time  responses,  it  is
difficult  to  conclude  whether  these  5  animals  had  truly
rejected their graft. They did not assess the endothelium in
their follow-up investigation [21].
Only Gong et al. [19] have so far provided a detailed
description of corneal clarity restoration in all grafts following
keratoplasty between Dark Agouti rats as donors and Lewis
rats as recipients. In their model, an opacity grade of 3 was
equalized with rejection, leading to a rejection rate of 100%,
followed by the clearing of all grafts over the following three
weeks.  Endothelial  cells  were  not  stained  specifically  but
recognized via nuclear morphology of corneal buttons. These
showed the absence of cells at the time of rejection, and a
continuous increase in cells in the following weeks. In our
experiments, ECs were stained using Alicarin red S to display
the  endothelial  cell  borders.  In  combination  with  DAPI
staining of the cell nucleus, this provides a more detailed
characterization of EC morphology and distribution compared
to previous studies.
Two models of re-endothelialization have been suggested
in the literature: the survival of donor endothelial cells with
subsequent  functional  recovery,  or  the  regeneration  of  an
endothelial cell layer by the host endothelium. Plskova et al.
[18]  postulated  that  donor  endothelial  cells  survive  the
immune response and regain their function. In their mouse
model, allogeneic keratoplasty lead to a variable degree of
graft opacity, with rejection defined as graft opacity greater
than  2.  While  a  clinically  assumed  rejection  was  mostly
associated with endothelial cell loss, the grade of graft opacity
did  not  accurately  reflect  the  degree  of  endothelial  cell
coverage. Those authors described endothelial cell migration
and cell enlargement, but felt that there was no evidence of
replacement by host endothelium [26]. A study by Hori et al.
[27] also demonstrated endothelial cell loss due to rejection
in a GFP mouse model, but unlike other authors, they did not
observe subsequent re-endothelialization. Accepted grafts (all
syngeneic  and  several  allogeneic  grafts)  kept  their
endothelium. They thus concluded that recipient endothelium
could not overgrow the donor corneal button. Their findings
contrast strongly to our observations in this study. In our
experiments,  we  noted  re-endothelialization  following
rejection, as well as after mechanical abrasion. Mechanical
abrasion guaranteed the use of completely EC-free transplants
Figure  5.  Immune  infiltration  and
corresponding  clinical  picture  (group
R). A, B: Group R: Rate of immune cells
infiltrating  the  graft  at  the  time  of
rejection (A; n=6). At this time point, the
graft is completely opaque (B). C, D:
Group  R:  Significant  reduction  in
infiltrating immune cells one year after
surgery  (C;  n=6;  *p<0.001).  Graft
clarity  is  restored  (D).  A  and  C:
Boxplots.  Arrows  in  B  and  D  mark
sutures indicating the graft border.
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2373in group S. These experiments enabled us to demonstrate that
recipient  endothelium  is  capable  of  extending  over  the
perforating  scar  of  the  transplant  edge,  and  capable  of
covering the grafted area. Moreover, we demonstrated that
these endothelial cells – although morphologically altered -
retain  their  functional  capacity  to  restore  corneal  clarity.
Analogously, we suggest a similar pattern of host-derived
endothelial regeneration in our allogeneic transplants of group
R. Although we did not prove the origin of the endothelial
cells in this set of experiments, this hypothesis could be further
tested by grafting experiments to GFP+ recipient rats or by
sex-mismatch  operations,  followed  by  analysis  of  the
regenerated allograft endothelium for GFP-expression or for
sex chromatin expression, respectively.
At  the  time  of  rejection,  a  strong  immunological
infiltration with a variety of leukocytes (Figure 5A) coincides
with complete EC loss (Figure 1B,C). The combination of
both leads to complete graft opacity, defined as graft rejection.
In contrast, the EC loss without immune response in group S
with endothelial abrasion resulted only in a relative opacity of
≤grade 3. Thus, since a clinically-apparent grade 3 can be
achieved  without  an  allogeneic  immune  response,  we
recommend using only complete graft opacity (grade 4) as the
clinical rejection criterion in this rat model.
Gong  et  al.  [19]  described  re-endothelialization  of
corneal allografts in the rat. We not only can confirm their
observation, we are the first to also analyze the role of the
immune  reaction  in  this  context.  The  immunological
infiltration we observed throughout the graft at the time of
rejection (Figure 5A) later subsides (Figure 5C). Analogous
to  the  coincidence  of  maximum  immune  cell  infiltration,
endothelial cell loss, and complete opacity at the time of
rejection, the subsequent reduction in leukocyte infiltration
coincides with restored corneal clarity. Since the endothelium
is thought to be the major target for an immunological allo-
response, we hypothesize that, following complete rejection,
the  immune  reaction  subsides  due  to  destruction  of  the
allogeneic cellular material. Corneal clarity may thereafter be
restored by syngeneic host corneal endothelium that does not
provoke further immune stimulation. However, as mentioned
above, to prove this theory it would be necessary to directly
determine EC origin, e.g., by using GFP transgenic animals
or detecting Y-chromosomes in sex mismatch PKP settings.
We also investigated EC recovery mechanisms. Loss of
contact inhibition due to the large defect in the EC layer might
be  the  stimulus  for  the  cells  to  migrate  and  enlarge.  EC
proliferation  has  also  been  hypothesized  in  this  context.
However, that was based on the morphological arrangement
of  cell  nuclei,  and  nothing  has  been  reported  on  specific
proliferation markers in this context so far [19]. In our set of
experiments, we demonstrated Ki-67+ -cells of the endothelial
cell layer on corneal flatmounts. This antigen is expressed
during all active phases of the cell cycle and thus acts as a
widely-used proliferation marker [28]. We detected dividing
cells  close  to  the  graft  border  (Figure  4F),  a  finding  that
supports  observations  made  by  Tuft  et  al.,  who  found
endothelial cell divisions at the margin of corneal endothelial
wounds in rats [14]. Without an EC wound’s stimulus, EC
division does not occur in the adult rat [29]. Dividing ECs in
vivo have been found in animals other than the rat that have
been used in corneal experiments like rabbit [15,30], rhesus
monkeys [15], and cats [16,17]. Even though in vitro assays
and experiments with cultured corneas suggested a higher
incidence  of  endothelial  precursor  cells  in  the  corneal
periphery  [13,31],  we  only  observed  Ki-67+  cells  in  the
endothelial cell layer close to the graft border and not in the
periphery of the host corneas.
In summary, our experiments demonstrate that in vivo re-
endothelialization exists following PKP in the rat. The host
endothelium is capable of repopulating an EC-free graft with
functional endothelium. This seems to occur by a combination
of cell enlargement and cell shift from the host toward the
graft, and by local cell division. Following a rejection episode
which destroys the corneal endothelium, the immune reaction
subsides,  and  the  number  of  infiltrating  cells  diminishes
dramatically  over  the  following  weeks  and  months.  The
formerly opaque graft regains its clarity, and endothelial cells
re-cover the graft. Even though the new endothelial cell layer
is morphologically altered, it seems sufficient to restore graft
clarity.
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